You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Dr. Linda Rabeneck – Vice-President, Prevention & Cancer Control

As the Vice-President, Prevention and Cancer Control, Dr. Linda Rabeneck oversees Cancer Care Ontario’s prevention, screening, research and surveillance programs.
Dr. Rabeneck is a gastroenterologist and clinician scientist. She is Professor of Medicine, Professor of Health Policy, Management and Evaluation, and Professor, Dalla Lana School of Public Health at the University of Toronto and Senior Scientist at the Institute for Clinical Evaluative Sciences (ICES) in Toronto. She is a Master of the American College of Gastroenterology and President-Elect of the Canadian Academy of Health Sciences.

Dr. Rabeneck received her medical degree from the University of British Columbia (UBC). She completed post-graduate training in internal medicine and gastroenterology at the UBC and the University of Toronto. She received her Master’s degree in Public Health from Yale University, where she trained as a Robert Wood Johnson Clinical Scholar. Dr. Rabeneck previously served as Director of the Division of Gastroenterology at the University of Toronto, and Regional Vice President, Cancer Care Ontario and Chief of the Odette Cancer Centre at Sunnybrook Health Sciences Centre.

Dr. Rabeneck played a leadership role in launching ColonCancerCheck in Ontario, Canada’s first organized, province-wide colorectal cancer screening program. She leads an active research program focusing on the quality and effectiveness of colorectal cancer screening, and has authored greater than 200 peer reviewed publications. Dr. Rabeneck is Chair of the World Endoscopy Organization (WEO) Colorectal Cancer Screening Committee, which holds international fora to discuss new information on colorectal cancer screening and promote the implementation of CRC screening.